B. Riley Issues Positive Forecast for Cytokinetics (NASDAQ:CYTK) Stock Price
B. Riley raised their price target on Cytokinetics from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday.
Source link
Similar Posts
Why Most Trading Bots Blow Up Small Accounts and How to Protect Yours
Starting with a small account feels like the smart way to begin in automated trading. You reduce your risk, stay cautious, and test the waters… right? But for many traders, it ends in disaster.Margin calls. Blown balances. And confusion about why the backtest looked so promising. So what’s going wrong? In this post, I’ll break…
Bitcoin vs. Gold: A 2025 Growth Comparison in the Current Market Landscape
As we move through the second half of 2025, the financial markets are witnessing a fascinating divergence between two major store-of-value assets: Bitcoin (BTC) and Gold (XAU). While both have long been used as hedges against economic uncertainty, their performance in 2025 reflects two very different growth stories shaped by technology, regulation, and global sentiment….
ICHIMOKU CLOUD TRADING STRATEGIES EA MT4/MT5 BACKTESTS & NEW OPTIMIZED SET FILES
For the ICHIMOKU CLOUD TRADING EA MT4/MT5 my current recommendation is to trade only these set files EURUSD, USDCHF, AUDUSD, GBPUSD ,USDCAD,NZDUSD AND XAUUSD with specific settings How Different Strategies related to ichimoku works? 1. Kijun Cross Strategy # Define Buy and Sell Logic for Kijun Cross Strategy def kijun_cross_buy_signal(): return price > kijun_sen and…
